Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 1.1 Exhibit 1.1
- 1.2 Exhibit 1.2
- 2.1 Exhibit 2.1
- 2.7 Exhibit 2.7
- 4.16 Exhibit 4.16
- 4.16.1 Exhibit 4.16.1
- 4.17 Exhibit 4.17
- 4.18 Exhibit 4.18
- 4.19 Exhibit 4.19
- 8.1 Exhibit 8.1
- 12.1 Exhibit 12.1
- 12.2 Exhibit 12.2
- 13.1 Exhibit 13.1
- 13.2 Exhibit 13.2
- 15.1 Exhibit 15.1
- Download Excel data file
- View Excel data file
AMYT similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated April 29, 2022, with respect to the consolidated financial statements included in the Annual Report of Amryt Pharma plc on Form 20-F for the year ended December 31, 2021. We consent to the incorporation by reference of said reports in the following Registration Statement of Amryt Pharma plc on Form S-8 (File No. 333-239763).
/s/ GRANT THORNTON
Dublin, Ireland
April 29, 2022